ZICAM SINUS RELIEF 0.05 % — DIN 02313618
OXYMETAZOLINE HYDROCHLORIDE : 0.05 % · ZICAM LLC · SOLUTION · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is ZICAM SINUS RELIEF?
ZICAM SINUS RELIEF 0.05 % contains OXYMETAZOLINE HYDROCHLORIDE : 0.05 %. It is listed in the Health Canada Drug Product Database under DIN 02313618, held by ZICAM LLC, supplied as SOLUTION for NASAL administration. Health Canada currently lists it as cancelled post market, status dated 20-Nov-2009. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Oxymetazoline cost around the world?
Oxymetazoline is listed on 3 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Saudi Arabia publishes a public; South Africa publishes a single exit price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Saudi Arabia | public | 8 | 8 | SAR███.██ |
| South Africa | single exit price | 5 | 6 | ZAR███.██ |
| Australia | ex-manufacturer | 4 | 4 | AUD███.██ |
18 pack listings across 17 brand entries and 3 price bases, refreshed 08 Sep 2026. Ranges span every Oxymetazoline pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Oxymetazoline in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
16 holders have a Canadian DIN containing Oxymetazoline, across 42 DINs, of which 13 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BAYER INC | 12 | 8 | AESB - OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION USP, 0.025%, CLARITIN ALLERGY DECONGESTANT, DRIXORAL DECONGESTANT NASAL SPRAY, DRIXORAL NASAL CONGESTION, DRIXORAL NO DRIP COOLING MENTHOL, +7 more | Sourceable in Canada |
| FOUNDATION CONSUMER BRANDS, LLC | 2 | 2 | LONG LASTING DRISTAN MENTHOLATED NASAL SPRAY, LONG LASTING DRISTAN NASAL MIST | Sourceable in Canada |
| JUNO OTC INC | 2 | 2 | EXTRA MOISTURIZING NASAL SPRAY, NASAL CONGESTION SPRAY | Sourceable in Canada |
| CRLS | 1 | 1 | LONG LASTING DECONGESTANT NASAL SPRAY | Sourceable in Canada |
| PROCTER & GAMBLE INC | 5 | 0 | SINEX COMPLETE, SINEX MOISTURIZING ULTRA FINE MIST, SINEX ORIGINAL ULTRA FINE MIST, SINEX SCENT FREE ULTRA FINE MIST, VICKS SINEX DECONGESTANT NASAL SPRAY 0.05% | No marketed DIN |
| GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | 4 | 0 | OTRIVIN MEDICATED NO DRIP, OTRIVIN MEDICATED SINUS, OXYMETAZOLINE HYDROCHLORIDE NASAL SPRAY 0.05%, OXYMETAZOLINE HYDROCHLORIDE NASAL SPRAY 0.05% WITH MOISTURIZERS | No marketed DIN |
| TEVA CANADA LIMITED | 3 | 0 | COOLING MENTHOL NASAL SPRAY, EXTRA MOISTURIZING NASAL SPRAY, NASAL CONGESTION SPRAY | No marketed DIN |
| NEILMED PHARMACEUTICALS INC | 2 | 0 | SINUFRIN, SINUFRIN PLUS | No marketed DIN |
| RECKITT BENCKISER (CANADA) INC | 2 | 0 | MUCINEX SINUS-ACTION CONGESTION & SINUS NASAL SPRAY, MUCINEX SINUS-ACTION MOISTURE SMART NASAL SPRAY | No marketed DIN |
| SCHERING-PLOUGH CANADA INC | 2 | 0 | AFRIN COLD, NAFRINE PEDIATRIC NASAL SPRAY/DROPS 0.025% | No marketed DIN |
| ZICAM LLC | 2 | 0 | ZICAM CONGESTION RELIEF, ZICAM SINUS RELIEF | No marketed DIN |
| JAMP PHARMA CORPORATION | 1 | 0 | LONG LASTING NASAL MIST | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.05 % |
|---|---|
| Dosage form | SOLUTION |
| Route | NASAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Oxymetazoline |
|---|---|
| ATC code | R01AA05 |
| AHFS class | 52:32.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02313618 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2313618 |
| Brand name | ZICAM SINUS RELIEF |
| Generic / active ingredient | OXYMETAZOLINE HYDROCHLORIDE : 0.05 % |
| Market authorization holder | ZICAM LLC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01AA05 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R01AA |
| Current status | CANCELLED POST MARKET |
| Status date | 20-Nov-2009 |
| Original market date | 2008-11-27 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
13 of 42 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| CLARITIN ALLERGY DECONGESTANT | 0.05 % | SOLUTION | BAYER INC | MARKETED | 02243690 |
| DRIXORAL DECONGESTANT NASAL SPRAY | 0.05 % | SOLUTION | BAYER INC | MARKETED | 00740861 |
| DRIXORAL NASAL CONGESTION | 0.05 % | SPRAY | BAYER INC | MARKETED | 02380129 |
| DRIXORAL NO DRIP COOLING MENTHOL | 0.05 % | SPRAY | BAYER INC | MARKETED | 02245580 |
| DRIXORAL NO DRIP EXTRA MOISTURIZING | 0.05 % | SPRAY | BAYER INC | MARKETED | 02245575 |
| DRIXORAL NO DRIP NASAL CONGESTION | 0.05 % | SPRAY | BAYER INC | MARKETED | 02498294 |
| DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL | 0.05 % | SPRAY | BAYER INC | MARKETED | 02498308 |
| DRIXORAL NO DRIP ORIGINAL UNSCENTED | 0.05 % | SPRAY | BAYER INC | MARKETED | 02245578 |
| EXTRA MOISTURIZING NASAL SPRAY | 0.05 % | SPRAY, METERED DOSE | JUNO OTC INC | MARKETED | 02460572 |
| LONG LASTING DECONGESTANT NASAL SPRAY | 0.05 % | SPRAY | CRLS | MARKETED | 02454351 |
2 · Same class — other molecules in ATC R01AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Oxymetazoline | AESB - OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION USP, 0.025% · AFRIN COLD · CLARITIN ALLERGY DECONGESTANT · COOLING MENTHOL NASAL SPRAY · +34 more | 42 | 13 | Yes |
| Xylometazoline | BALMINIL DECONGEST · BALMINIL NASAL DECONGESTANT · CERTIFIED DECONGESTANT NASAL SPRAY .1% · COLD & ALLERGY RELIEF · +24 more | 31 | 5 | Yes |
| Phenylephrine | NEO SYNEPHRINE NASAL DROP 1% · NEO-SYNEPHRINE NASAL DROP 1% | 2 | 0 | Not in Canada |
| Ephedrine | FORMULE G8 LIQ 1.5% | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R01AD | Beclomethasone · Budesonide · Ciclesonide · Flunisolide · Fluticasone · +5 more | 55 | 24 |
| R01AX | Combinations · Ipratropium Bromide · Various | 42 | 4 |
| R01AB | Ephedrine · Naphazoline · Oxymetazoline · Phenylephrine | 12 | 1 |
| R01AC | Cromoglicic Acid · Levocabastine | 6 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is ZICAM SINUS RELIEF called?
The same molecule, Oxymetazoline, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| ClariSpray Menthol | Latin | Saudi Arabia |
| ClariSpray Original | Latin | Saudi Arabia |
| Drixine | Latin | Australia |
| ILIADIN | Latin | Saudi Arabia |
| ILIADIN ADULT | Latin | Saudi Arabia |
| ILIADIN INFANT | Latin | Saudi Arabia |
| Logicin Rapid Relief | Latin | Australia |
| Nazene Z Nasal Spray | Latin | South Africa |
| Pharmacy Action Nasal Decongestant | Latin | Australia |
| Trust Decongestant Nasal Spray | Latin | Australia |
| VICKS SINEX NASAL SPRAY. | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.